Compare BBNX & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBNX | MAGN |
|---|---|---|
| Founded | 2015 | 1864 |
| Country | United States | United States |
| Employees | N/A | 2980 |
| Industry | Medical/Dental Instruments | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 435.4M |
| IPO Year | 2025 | 1994 |
| Metric | BBNX | MAGN |
|---|---|---|
| Price | $19.50 | $12.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $23.80 | $12.00 |
| AVG Volume (30 Days) | ★ 960.2K | 451.3K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.95 | 7.64 |
| EPS | ★ N/A | N/A |
| Revenue | $100,251,000.00 | ★ $3,204,000,000.00 |
| Revenue This Year | $34.90 | $5.37 |
| Revenue Next Year | $34.63 | $3.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 53.94 | 46.50 |
| 52 Week Low | $8.80 | $7.82 |
| 52 Week High | $32.71 | $15.52 |
| Indicator | BBNX | MAGN |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 50.91 |
| Support Level | $9.34 | $11.64 |
| Resistance Level | $20.74 | $12.96 |
| Average True Range (ATR) | 1.05 | 0.50 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 63.55 | 72.81 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.